Orchestra BioMed Holdings OBIO Ratios (2020-2026)

NASDAQ OBIO
$6.01 +0.28 (+4.89%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Orchestra BioMed Holdings Quarterly Ratios

Periods 25 quarters
Latest Sep 2026

Orchestra BioMed Holdings reported a gross margin of 69.23% and a net margin of -21,557.14% for the quarter ended Sep 2026. These financial ratios cover 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
95.15%85.04%95.18%95.19%96.22%94.10%90.21%82.06%94.52%94.34%93.11%77.08%94.93%94.50%94.31%99.84%70.91%71.59%69.23%
EBT Margin
-590.50%-1,853.05%-854.63%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%-25,404.55%-25,600.00%
EBIT Margin
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%-25,404.55%-25,600.00%
EBITDA Margin
-580.25%-1,882.29%-857.87%-881.41%-982.65%-1,403.93%-3,440.81%-4,735.11%-2,314.35%-2,157.46%-1,648.02%-6,558.50%-2,164.98%-2,296.65%-2,342.97%22.32%-19,929.09%-25,221.59%-25,417.58%
Operating Margin
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%-25,404.55%-25,600.00%
Net Margin
-661.55%-1,956.86%-884.09%-883.95%-939.86%-1,316.50%-3,178.04%-4,892.37%-2,171.45%-2,053.98%-1,562.92%-6,385.38%-2,160.71%-2,316.15%-2,419.05%19.38%-18,778.18%-27,362.50%-21,557.14%
FCF Margin
-620.21%-2,052.62%-643.16%-797.64%-1,238.49%-1,149.40%-2,458.47%-4,187.40%-2,116.45%-1,325.58%-1,394.93%-5,392.89%-1,927.19%-1,861.36%-1,725.90%-7.45%-20,320.00%-22,256.82%-21,907.69%
Efficiency
Inventory AverageInventory Avg.
0.25M0.21M0.16M0.14M0.13M0.09M0.15M0.20M0.15M0.16M0.28M0.34M0.29M0.26M0.24M
Assets AverageAssets Avg.
161.85M161.68M161.55M115.12M82.11M115.93M131.08M121.12M105.78M88.92M77.51M73.85M75.75M67.61M50.94M73.82M109.83M107.76M108.18M111.72M
Equity AverageEquity Avg.
-11.82M-9.85M34.79M65.47M56.98M76.14M94.60M84.55M73.85M62.62M50.66M45.17M39.59M24.91M8.58M22.02M48.65M47.38M30.26M13.55M
Invested CapitalInvested Cap.
300,069.51M62.02M109.28M99.00M89.26M47.25M31.20M14.68M57.94M67.84M55.53M33.72M22.24M
Asset Utilization RatioAsset Util.
0.040.030.030.030.030.020.030.040.030.040.060.040.300.300.300.28
Leverage & Solvency
Debt Ratio
0.00M0.100.070.080.080.190.240.340.140.120.140.120.13
Valuation
Price to SalesP/S
46.40162.1457.5886.56118.3585.10140.4473.6857.9156.8235.1849.697.077.618.1212.25
Price to BookP/B
0.00M2.932.213.126.232.803.914.803.306.624.224.649.73351.073.204.426.0513.4449.12
Enterprise Value
204.38M201.24M202.38M135.12M80.23M494.04M132.50M203.20M239.12M113.57M226.79M128.10M85.97M114.09M69.64M44.21M139.98M164.55M159.79M291.29M
Market Capitalization
206.14M202.66M203.68M135.85M163.93M621.17M250.20M311.69M326.65M188.59M291.97M195.03M152.78M163.98M103.56M140.03M236.69M249.18M259.65M382.24M
Price to FCFP/FCF
EV to FCF
EV to CFO
Return Ratios
Return on Sales [ROS]ROS
-592.15%-1,903.74%-865.61%-891.02%-991.84%-1,415.96%-3,466.35%-4,763.74%-2,326.29%-2,166.97%-1,655.72%-6,591.70%-2,179.84%-2,311.84%-2,359.23%21.85%-20,069.09%-25,404.55%-25,600.00%
Return on Capital Employed [ROCE]ROCE
-0.24%-3.35%-8.07%-20.16%-51.39%-37.62%-37.24%-49.03%-54.46%-69.28%-92.52%-104.29%-108.00%-131.99%-210.37%-141.53%-55.65%-58.43%-61.23%-62.54%
Return on Assets [ROA]ROA
-0.23%-3.71%-8.51%-20.80%-40.94%-33.52%-32.89%-38.09%-46.44%-58.05%-71.61%-77.88%-80.48%-98.02%-136.75%-101.81%-47.98%-50.78%-54.66%-51.15%
Return on Equity [ROE]ROE
-39.53%-36.58%-59.00%-51.03%-45.58%-54.56%-66.52%-82.43%-109.57%-127.32%-153.99%-266.07%-812.27%-341.35%-108.30%-115.48%-195.41%-421.69%

Orchestra BioMed Holdings Ratios API

Pull Orchestra BioMed Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OBIO&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY